Format

Send to

Choose Destination
Circulation. 2014 Aug 26;130(9):e85. doi: 10.1161/CIRCULATIONAHA.114.010275.

Response to letter regarding article, "Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study".

Author information

1
European Georges Pompidou Hospital and Paris Descartes University, Paris, France.
2
Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, ON, Canada.
3
Boehringer Ingelheim Pharma GmbH & Co KG, Clinical Development and Medical Affairs, Ingelheim am Rhein, Germany, Medical Faculty Mannheim of the University of Heidelberg, Heidelberg, Germany.
4
Cardiovascular Research Foundation and Thomas Jefferson Medical College, New York, NY.
5
Uppsala Clinical Research Centre, University Hospital, Uppsala, Sweden.
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center